Document is current
Any future updates will be listed below
-
Authors
Li, Allen https://orcid.org/0000-0001-7482-8204
Keck, Jamie M.
Parmar, Swapnil
Patterson, Janice https://orcid.org/0000-0002-8969-2933
Labrie, Marilyne https://orcid.org/0000-0003-3957-5533
Creason, Allison L. https://orcid.org/0000-0001-5724-1276
Johnson, Brett E. https://orcid.org/0000-0001-6810-551X
Downey, Molly https://orcid.org/0000-0001-5212-2286
Thomas, George
Beadling, Carol
Heiser, Laura M.
Kolodzie, Annette
Guimaraes, Alexander R.
Corless, Christopher L.
Gray, Joe W. https://orcid.org/0000-0001-9225-6756
Mills, Gordon B. https://orcid.org/0000-0002-0144-9614
Bergan, Raymond C. https://orcid.org/0000-0001-8690-4876
Mitri, Zahi I. https://orcid.org/0000-0001-8765-7723
- License Information
-
More Information
Article History
Received: 27 August 2020
Accepted: 24 February 2021
First Online: 26 March 2021
Competing interests
: R.C.B.: Patents, Royalties, Other Intellectual Property: I hold several patents, and currently have two pending, related to small molecule therapeutics that inhibit cancer cell motility, bone destruction, and screening assays for potentially active drugs. Uncompensated Relationships: Hebei Provence Scientific Foundation; TapRoot. J.W.G.: Leadership: PDX Pharmacy, Convergent Genomics, Health Technology Innovations. Stock and Other Ownership Interests: Abbott Diagnostics, AbbVie, Amgen, ANI Pharmaceuticals, Agilent, Gilead Sciences, Zimmer BioMet, AMD. Consulting or Advisory Role: Colorado School of Mines, Murdock Trust, New Leaf Venture, Susan G. Komen for the Cure, University of New Mexico Comprehensive Cancer Center, University of Minnesota, Radiation Effects Research Foundation, University of Colorado Denver. Research Funding: Micron, PDX Phamaceuticals, Thermo Fisher Scientific, Danaher, Miltenyi Biotec. Patents, Royalties, Other Intellectual Property: Abbott, Cepheid, PDX Pharmacy. Travel, Accommodations, Expenses: Miltenyi Biotec, Radiation Effects Research Foundation. G.B.M.: SAB/Consultant: Amphista, AstraZeneca, Chrysallis Biotechnology, GSK, Ellipses Pharma, ImmunoMET, Ionis, Lilly, PDX Pharmaceuticals, Signalchem Lifesciences, Symphogen, Tarveda, Turbine, Zentalis Pharmaceuticals. Stock/ Options/Financial: Catena Pharmaceuticals, ImmunoMet, SignalChem, Tarveda. Licensed Technology HRD assay to Myriad Genetics, DSP patents with Nanostring. C.L.C.: Employment: Omics Data Automation, Inc. Leadership: Omics Data Automation, Inc. Stock and Other Ownership Interests: Guardant Health, Omics Data Automation, Inc. Honoraria: Roche, Deciphera. Consulting or Advisory Role: Roche, Thermo Fisher Scientific Biomarkers, Cepheid, Amgen. Research Funding: Arvinas, SpringWorks. Travel, Accommodations, Expenses: Roche, Thermo Fisher Scientific, Cepheid. Open Payments Link: . No other potential competing interests were reported.
